First Alleged U.S. Death from Defective Glucose Monitors Prompts Legal Action—7 Deaths Reported Globally, 3 Million Devices Recalled ONTARIO, Calif., Feb.

Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning ...

This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert (she/her/hers) was previously the ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device – which is ...

Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report ...

Guadalupe Zuñiga has been around wrestling masks for as long as she can remember. It is a relationship that began when she ...